Kailin Yu
5Patents
0h-index
25Co-inventors
34Inventor score
Filing activity: Aug 7, 2015 → Dec 12, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10266535B2 | Inhibitor of FLT3 kinase and use thereof | Human Necessities | 0 | Active |
| US10669238B2 | Irreversible bruton's tyrosine kinase inhibitor | Emerging Cross-Sectional Technologies | 0 | Active |
| US11602534B2 | Pyrimidine derivative kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10781214B2 | Kinase inhibitor against wild-type and mutant EGFR | Human Necessities | 0 | Active |
| US12221448B2 | Selective PI3Kδ inhibitor and use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.